Real-World Evidence in Drug Development and Evaluation

729,-

Quantitative Drug Safety and Benefit Risk Evaluation

749,-

Advanced Statistics in Regulatory Critical Clinical Initiatives

2 329,-

Frailty Models in Survival Analysis

669,-

Multiple Testing Problems in Pharmaceutical Statistics

679,-

Theory of Drug Development

1 349,-

Real-World Evidence in a Patient-Centric Digital Era

648,-

Frailty Models in Survival Analysis

2 329,-

Hybrid Frequentist/Bayesian Power and Bayesian Power in Planning Clinical Trials

1 729,-

Group Sequential and Adaptive Methods for Clinical Trials

1 228,-

Real-World Evidence in Drug Development and Evaluation

729,-

Quantitative Drug Safety and Benefit Risk Evaluation

749,-

Advanced Statistics in Regulatory Critical Clinical Initiatives

2 329,-

Frailty Models in Survival Analysis

669,-

Multiple Testing Problems in Pharmaceutical Statistics

679,-

Theory of Drug Development

1 349,-

Real-World Evidence in a Patient-Centric Digital Era

648,-

Frailty Models in Survival Analysis

2 329,-

Hybrid Frequentist/Bayesian Power and Bayesian Power in Planning Clinical Trials

1 729,-

Group Sequential and Adaptive Methods for Clinical Trials

1 228,-